The U.S. Centers for Medicare and Medicaid Services has revised its policy permitting multiple uses of amyloid positron emission tomography (PET) scans, a non-invasive brain scan crucial for identifying amyloid plaques, a telltale sign of Alzheimer's.
"Amyloid PET scans are a proven tool and can be an important part of Alzheimer's diagnosis and treatment," Maria Carrillo, chief science officer of the Alzheimer's Association, said in a statement.
Related: Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
This shift is essential as ...